Rituximab Active Not Recruiting Phase 1 Trials for Peripheral T-Cell Lymphoma (PTCL) / Chronic Lymphocytic Leukaemia (CLL) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01671904A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)
NCT01644253Phase 1b Safety and Efficacy Study of TRU-016